跳至主要内容
临床试验/IRCT2016111016123N11
IRCT2016111016123N11已完成未知

Evaluation of the effects of Melatonin Supplementation on metabolic Syndrome components and plasma Leptin and Adiponectin levels in patients with metabolic Syndrome

Vice Chancellor for Research and Technology, Ahvaz Jundishapur University of Medical Sciences0 个研究点目标入组 80 人开始时间: 待定最近更新:
适应症

试验速览

阶段
未知
状态
已完成
发起方
入组人数
80

研究概览

简要总结

暂无简介。

研究设计

研究类型
Interventional

入排标准

年龄范围
18 years 至 60 years(—)
性别
All

入选标准

  • Age 18 years and older; having at least two of the five metabolic syndrome criteria including waist circumference in men greater than or equal to 102 cm and in women greater than or equal to 88 cm; triglycerides levels (TG) greater than or equal to 150 mg/dL; low-density lipoprotein cholesterol levels (HDL-c) less than or equal to 40 mg/dL in men and less than or equal to 50 mg/dL in women; blood pressure greater than or equal to 130 mmHg or under treatment of Hypertension; fasting blood sugar greater than or equal to 100 mg/dL. b -exclusion criteria: history of alcohol consumption; chronic and acute liver disorders (hepatitis B, C, ...); biliary diseases; autoimmune diseases; cancer; cardiovascular diseases; pulmonary diseases; kidney diseases; pregnancy; breast-feeding; use of contraceptives; hepatotoxic drugs consumption; use of Mineral- multivitamin supplements; weight loss surgery in the recent year; weight loss program in 3 month ago; history of hypothyroidism; Cushing's syndrome.

排除标准

  • 未提供

研究者

发起方
Vice Chancellor for Research and Technology, Ahvaz Jundishapur University of Medical Sciences

相似试验

Effects of Melatonin on Metabolic Syndrome disease | 临床试验